- Home
- Publications
- Publication Search
- Publication Details
Title
Vaccines for COVID‐19
Authors
Keywords
-
Journal
CLINICAL AND EXPERIMENTAL IMMUNOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-09-18
DOI
10.1111/cei.13517
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Novel antibody epitopes dominate the antigenicity of spike glycoprotein in SARS-CoV-2 compared to SARS-CoV
- (2020) Ming Zheng et al. Cellular & Molecular Immunology
- Presumed Asymptomatic Carrier Transmission of COVID-19
- (2020) Yan Bai et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Identification of potential cross-protective epitope between 2019-nCoV and SARS virus
- (2020) Tianyi Qiu et al. Journal of Genetics and Genomics
- Development of epitope‐based peptide vaccine against novel coronavirus 2019 (SARS‐COV‐2): Immunoinformatics approach
- (2020) Manojit Bhattacharya et al. JOURNAL OF MEDICAL VIROLOGY
- A new coronavirus associated with human respiratory disease in China
- (2020) Fan Wu et al. NATURE
- A Novel Coronavirus from Patients with Pneumonia in China, 2019
- (2020) Na Zhu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Human parainfluenza virus type 3 expressing the respiratory syncytial virus pre-fusion F protein modified for virion packaging yields protective intranasal vaccine candidates
- (2020) Xueqiao Liu et al. PLoS One
- Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
- (2020) Daniel Wrapp et al. SCIENCE
- A codon-pair deoptimized live-attenuated vaccine against respiratory syncytial virus is immunogenic and efficacious in non-human primates
- (2020) Steffen Mueller et al. VACCINE
- Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies
- (2020) Syed Faraz Ahmed et al. Viruses-Basel
- Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody
- (2020) Xiaolong Tian et al. Emerging Microbes & Infections
- Understanding SARS-CoV-2-Mediated Inflammatory Responses: From Mechanisms to Potential Therapeutic Tools
- (2020) Yajing Fu et al. VIROLOGICA SINICA
- The role of IgA in COVID-19
- (2020) Yin Xia Chao et al. BRAIN BEHAVIOR AND IMMUNITY
- Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
- (2020) Alba Grifoni et al. CELL
- Immunopathological characteristics of coronavirus disease 2019 cases in Guangzhou, China
- (2020) Mingkai Tan et al. IMMUNOLOGY
- Alterations in Smell or Taste in Mildly Symptomatic Outpatients With SARS-CoV-2 Infection
- (2020) Giacomo Spinato et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Bioinformatic prediction of potential T cell epitopes for SARS-Cov-2
- (2020) Kazuma Kiyotani et al. JOURNAL OF HUMAN GENETICS
- Human Challenge Studies to Accelerate Coronavirus Vaccine Licensure
- (2020) Nir Eyal et al. JOURNAL OF INFECTIOUS DISEASES
- Ethical guidelines for deliberately infecting volunteers with COVID-19
- (2020) Adair D. Richards JOURNAL OF MEDICAL ETHICS
- Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial
- (2020) Feng-Cai Zhu et al. LANCET
- Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial
- (2020) Pedro M Folegatti et al. LANCET INFECTIOUS DISEASES
- WITHDRAWN: Is global BCG vaccination coverage relevant to the progression of SARS-CoV-2 pandemic?
- (2020) Mayda Gursel et al. MEDICAL HYPOTHESES
- The potential role of Th17 immune responses in coronavirus immunopathology and vaccine-induced immune enhancement
- (2020) Peter J. Hotez et al. MICROBES AND INFECTION
- The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice
- (2020) Linlin Bao et al. NATURE
- Real-time tracking of self-reported symptoms to predict potential COVID-19
- (2020) Cristina Menni et al. NATURE MEDICINE
- Vaccination strategies to enhance immunity in neonates
- (2020) Tobias R. Kollmann et al. SCIENCE
- Development of an inactivated vaccine candidate for SARS-CoV-2
- (2020) Qiang Gao et al. SCIENCE
- Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS–coronavirus 2
- (2020) Jianzhong Shi et al. SCIENCE
- Immunogenicity of a DNA vaccine candidate for COVID-19
- (2020) Trevor R. F. Smith et al. Nature Communications
- Persistence of viral RNA in stool samples from patients recovering from covid-19
- (2020) Roos E Barth et al. BMJ-British Medical Journal
- Emergence of SARS-CoV-2 through recombination and strong purifying selection
- (2020) Xiaojun Li et al. Science Advances
- COVID-19 vaccines: breaking record times to first-in-human trials
- (2020) Young Chan Kim et al. npj Vaccines
- SARS-CoV-2 infection in farmed minks, the Netherlands, April and May 2020
- (2020) Nadia Oreshkova et al. Eurosurveillance
- Lessons for COVID-19 Immunity from Other Coronavirus Infections
- (2020) Alan Sariol et al. IMMUNITY
- Analysis of a SARS-CoV-2-Infected Individual Reveals Development of Potent Neutralizing Antibodies with Limited Somatic Mutation
- (2020) Emilie Seydoux et al. IMMUNITY
- Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes
- (2020) Shengli Xia et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial
- (2020) Feng-Cai Zhu et al. LANCET
- Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
- (2020) Pedro M Folegatti et al. LANCET
- Design of a peptide-based subunit vaccine against novel coronavirus SARS-CoV-2
- (2020) Parismita Kalita et al. MICROBIAL PATHOGENESIS
- Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques
- (2020) Noe B. Mercado et al. NATURE
- Factors associated with COVID-19-related death using OpenSAFELY
- (2020) Elizabeth J. Williamson et al. NATURE
- Longitudinal analyses reveal immunological misfiring in severe COVID-19
- (2020) Carolina Lucas et al. NATURE
- A perspective on potential antibody-dependent enhancement of SARS-CoV-2
- (2020) Ann M. Arvin et al. NATURE
- Accelerating Development of SARS-CoV-2 Vaccines — The Role for Controlled Human Infection Models
- (2020) Meagan E. Deming et al. NEW ENGLAND JOURNAL OF MEDICINE
- BCG vaccine protection from severe coronavirus disease 2019 (COVID-19)
- (2020) Luis E. Escobar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Can existing live vaccines prevent COVID-19?
- (2020) Konstantin Chumakov et al. SCIENCE
- Could an Unrelated Live Attenuated Vaccine Serve as a Preventive Measure To Dampen Septic Inflammation Associated with COVID-19 Infection?
- (2020) Paul L. Fidel et al. mBio
- Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in mice
- (2020) Paul F. McKay et al. Nature Communications
- Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19
- (2020) Christoph D. Spinner et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia
- (2020) Denis Y Logunov et al. LANCET
- Legal agreements: barriers and enablers to global equitable COVID-19 vaccine access
- (2020) Alexandra L Phelan et al. LANCET
- Coronavirus envelope protein: current knowledge
- (2019) Dewald Schoeman et al. Virology Journal
- Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial
- (2019) Kayvon Modjarrad et al. LANCET INFECTIOUS DISEASES
- Virus-Like Particles as an Instrument of Vaccine Production
- (2019) B. V. Syomin et al. MOLECULAR BIOLOGY
- Structural basis for human coronavirus attachment to sialic acid receptors
- (2019) M. Alejandra Tortorici et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- HLA-Class II Artificial Antigen Presenting Cells in CD4+ T Cell-Based Immunotherapy
- (2019) Alexandre Couture et al. Frontiers in Immunology
- Recent Advances in the Vaccine Development Against Middle East Respiratory Syndrome-Coronavirus
- (2019) Chean Yeah Yong et al. Frontiers in Microbiology
- Humoral Immunogenicity and Efficacy of a Single Dose of ChAdOx1 MERS Vaccine Candidate in Dromedary Camels
- (2019) Naif Khalaf Alharbi et al. Scientific Reports
- A review of Dengvaxia®: development to deployment
- (2019) Stephen J. Thomas et al. Human Vaccines & Immunotherapeutics
- Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry
- (2019) Yushun Wan et al. JOURNAL OF VIROLOGY
- The Safety and Immunogenicity of GTU®MultiHIV DNA Vaccine Delivered by Transcutaneous and Intramuscular Injection With or Without Electroporation in HIV-1 Positive Subjects on Suppressive ART
- (2019) G. Haidari et al. Frontiers in Immunology
- Vaccination-induced herd immunity: Successes and challenges
- (2018) Michael L. Mallory et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials
- (2018) Martin R Gaudinski et al. LANCET
- Self-Amplifying RNA Vaccines Give Equivalent Protection against Influenza to mRNA Vaccines but at Much Lower Doses
- (2018) Annette B. Vogel et al. MOLECULAR THERAPY
- Effect of Dengue Serostatus on Dengue Vaccine Safety and Efficacy
- (2018) Saranya Sridhar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Protection induced by virus-like particle vaccine containing tandem repeat gene of respiratory syncytial virus G protein
- (2018) Ah-Ra Kim et al. PLoS One
- Examination of the effects of virus inactivation methods on the induction of antibody- and cell-mediated immune responses against whole inactivated H9N2 avian influenza virus vaccines in chickens
- (2018) Jake Astill et al. VACCINE
- Adjuvanted influenza vaccines
- (2018) John S. Tregoning et al. Human Vaccines & Immunotherapeutics
- Enhanced protection in mice induced by immunization with inactivated whole viruses compare to spike protein of middle east respiratory syndrome coronavirus
- (2018) Yao Deng et al. Emerging Microbes & Infections
- RNA sensors of the innate immune system and their detection of pathogens
- (2017) Nanhua Chen et al. IUBMB LIFE
- Return on investment of public health interventions: a systematic review
- (2017) Rebecca Masters et al. JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH
- Induction of an IFN-Mediated Antiviral Response by a Self-Amplifying RNA Vaccine: Implications for Vaccine Design
- (2017) Timothy Pepini et al. JOURNAL OF IMMUNOLOGY
- Adjuvant effects of a sequence-engineered mRNA vaccine: translational profiling demonstrates similar human and murine innate response
- (2017) Darin K. Edwards et al. Journal of Translational Medicine
- Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)
- (2017) Ana Maria Henao-Restrepo et al. LANCET
- Optimizing assembly and production of native bispecific antibodies by codon de-optimization
- (2016) Giovanni Magistrelli et al. mAbs
- Immunization with inactivated Middle East Respiratory Syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virus
- (2016) Anurodh Shankar Agrawal et al. Human Vaccines & Immunotherapeutics
- Recent advances in the production of recombinant subunit vaccines inPichia pastoris
- (2016) Man Wang et al. Bioengineered
- Comparison of Pandemrix and Arepanrix, two pH1N1 AS03-adjuvanted vaccines differentially associated with narcolepsy development
- (2015) Louis Jacob et al. BRAIN BEHAVIOR AND IMMUNITY
- Severe Acute Respiratory Syndrome Coronaviruses with Mutations in the E Protein Are Attenuated and Promising Vaccine Candidates
- (2015) Jose A. Regla-Nava et al. JOURNAL OF VIROLOGY
- Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial
- (2015) Katrin Ramsauer et al. LANCET INFECTIOUS DISEASES
- A Cysteine Zipper Stabilizes a Pre-Fusion F Glycoprotein Vaccine for Respiratory Syncytial Virus
- (2015) Guillaume B. E. Stewart-Jones et al. PLoS One
- Alum Adjuvant Enhances Protection against Respiratory Syncytial Virus but Exacerbates Pulmonary Inflammation by Modulating Multiple Innate and Adaptive Immune Cells
- (2015) Ki-Hye Kim et al. PLoS One
- Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2
- (2015) Syed Sohail Ahmed et al. Science Translational Medicine
- Prefusion F–specific antibodies determine the magnitude of RSV neutralizing activity in human sera
- (2015) Joan O. Ngwuta et al. Science Translational Medicine
- Influence of elemental impurities in aluminum hydroxide adjuvant on the stability of inactivated Japanese Encephalitis vaccine, IXIARO®
- (2015) Robert Schlegl et al. VACCINE
- Development of animal models against emerging coronaviruses: From SARS to MERS coronavirus
- (2015) Troy C. Sutton et al. VIROLOGY
- Optimization of antigen dose for a receptor-binding domain-based subunit vaccine against MERS coronavirus
- (2015) Jian Tang et al. Human Vaccines & Immunotherapeutics
- Intranasal nanoemulsion-based inactivated respiratory syncytial virus vaccines protect against viral challenge in cotton rats
- (2015) Jessica J O'Konek et al. Human Vaccines & Immunotherapeutics
- Dissecting the indirect effects caused by vaccines into the basic elements
- (2015) Carla D Scarbrough Lefebvre et al. Human Vaccines & Immunotherapeutics
- Adenovirus Vectors for Gene Therapy, Vaccination and Cancer Gene Therapy
- (2014) William Wold et al. CURRENT GENE THERAPY
- T cell-mediated immune response to respiratory coronaviruses
- (2014) Rudragouda Channappanavar et al. IMMUNOLOGIC RESEARCH
- Prior Immunization with Severe Acute Respiratory Syndrome (SARS)-Associated Coronavirus (SARS-CoV) Nucleocapsid Protein Causes Severe Pneumonia in Mice Infected with SARS-CoV
- (2014) F. Yasui et al. JOURNAL OF IMMUNOLOGY
- Virus-Specific Memory CD8 T Cells Provide Substantial Protection from Lethal Severe Acute Respiratory Syndrome Coronavirus Infection
- (2014) R. Channappanavar et al. JOURNAL OF VIROLOGY
- Transmission of MERS-Coronavirus in Household Contacts
- (2014) Christian Drosten et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antigenic Differences between AS03 Adjuvanted Influenza A (H1N1) Pandemic Vaccines: Implications for Pandemrix-Associated Narcolepsy Risk
- (2014) Outi Vaarala et al. PLoS One
- Searching for an ideal vaccine candidate among different MERS coronavirus receptor-binding fragments—The importance of immunofocusing in subunit vaccine design
- (2014) Cuiqing Ma et al. VACCINE
- Intranasal vaccination with recombinant receptor-binding domain of MERS-CoV spike protein induces much stronger local mucosal immune responses than subcutaneous immunization: Implication for designing novel mucosal MERS vaccines
- (2014) Cuiqing Ma et al. VACCINE
- Dendritic cells process synthetic long peptides better than whole protein, improving antigen presentation and T-cell activation
- (2013) Rodney A. Rosalia et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The Receptor Binding Domain of the New Middle East Respiratory Syndrome Coronavirus Maps to a 231-Residue Region in the Spike Protein That Efficiently Elicits Neutralizing Antibodies
- (2013) H. Mou et al. JOURNAL OF VIROLOGY
- DNA Vaccine Delivered by a Needle-Free Injection Device Improves Potency of Priming for Antibody and CD8+ T-Cell Responses after rAd5 Boost in a Randomized Clinical Trial
- (2013) Barney S. Graham et al. PLoS One
- Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody
- (2013) J. S. McLellan et al. SCIENCE
- Engineering a Replication-Competent, Propagation-Defective Middle East Respiratory Syndrome Coronavirus as a Vaccine Candidate
- (2013) F. Almazan et al. mBio
- Tolerability of intramuscular and intradermal delivery by CELLECTRA®adaptive constant current electroporation device in healthy volunteers
- (2013) Malissa C Diehl et al. Human Vaccines & Immunotherapeutics
- Mechanisms of Action of Adjuvants
- (2013) Sunita Awate et al. Frontiers in Immunology
- Recombinant vaccines and the development of new vaccine strategies
- (2012) I.P. Nascimento et al. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
- Influenza vaccines and immunopathology
- (2012) Sarah C Gilbert Expert Review of Vaccines
- Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus
- (2012) Chien-Te Tseng et al. PLoS One
- A Double-Inactivated Severe Acute Respiratory Syndrome Coronavirus Vaccine Provides Incomplete Protection in Mice and Induces Increased Eosinophilic Proinflammatory Pulmonary Response upon Challenge
- (2011) M. Bolles et al. JOURNAL OF VIROLOGY
- Vaccine Adjuvants: Putting Innate Immunity to Work
- (2010) Robert L. Coffman et al. IMMUNITY
- T Cell Responses Are Required for Protection from Clinical Disease and for Virus Clearance in Severe Acute Respiratory Syndrome Coronavirus-Infected Mice
- (2010) J. Zhao et al. JOURNAL OF VIROLOGY
- Mammalian microRNAs predominantly act to decrease target mRNA levels
- (2010) Huili Guo et al. NATURE
- Interactions of SARS Coronavirus Nucleocapsid Protein with the host cell proteasome subunit p42
- (2010) Qin Wang et al. Virology Journal
- Comparing Pooled Peptides with Intact Protein for Accessing Cross-presentation Pathways for Protective CD8+and CD4+T Cells
- (2009) Hongwei Zhang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cellular Immune Responses to Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Infection in Senescent BALB/c Mice: CD4+ T Cells Are Important in Control of SARS-CoV Infection
- (2009) J. Chen et al. JOURNAL OF VIROLOGY
- STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity
- (2009) Hiroki Ishikawa et al. NATURE
- Humoral and Cellular Immune Responses Induced by 3a DNA Vaccines against Severe Acute Respiratory Syndrome (SARS) or SARS-Like Coronavirus in Mice
- (2008) B. Lu et al. Clinical and Vaccine Immunology
- Inflammatory signals in dendritic cell activation and the induction of adaptive immunity
- (2008) Olivier Joffre et al. IMMUNOLOGICAL REVIEWS
- Vaccine adjuvant systems: Enhancing the efficacy of sub-unit protein antigens
- (2008) Yvonne Perrie et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability
- (2008) Katalin Karikó et al. MOLECULAR THERAPY
- Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease
- (2008) Maria Florencia Delgado et al. NATURE MEDICINE
- A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial
- (2008) Julie E. Martin et al. VACCINE
- Vaccine-induced enhancement of viral infections
- (2008) W. Huisman et al. VACCINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started